AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ATOMO DIAGNOSTICS LTD

0.041

0.000

Volume:- -

Turnover:- -

Market Cap:33.22M

PE:-5.34

High:0.041

Open:0.041

Low:0.041

Close:0.041

52wk High:0.048

52wk Low:0.014

Shares:810.18M

Float Shares:423.51M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.008

ROE:-58.27%

ROA:-35.32%

PB:4.76

PE(LYR):-5.34

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment-8.23%

Capital Flow

Inflow:

Outflow:

News

BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal

BUZZ-Australia's Atomo Diagnostics jumps on new liver test license

Atomo Diagnostics - Agreement With Burnet Diagnostics Initiative

THOMSON REUTERS

Atomo Diagnostics - Exclusive Licence for a Novel Liver Function Test on Pascal

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AT1.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AT1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AT1.AU\",,,,,undefined,":{"symbol":"AT1.AU","market":"AU","secType":"STK","nameCN":"ATOMO DIAGNOSTICS LTD","latestPrice":0.041,"timestamp":1770764563426,"preClose":0.041,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"ATOMO DIAGNOSTICS LTD","floatShares":423507786,"shares":810175282,"eps":-0.007681,"marketStatus":"Trading","change":0,"latestTime":"02-11 10:07:38 AEDT","open":0.041,"high":0.041,"low":0.041,"amount":0,"amplitude":0,"askPrice":0.041,"askSize":285000,"bidPrice":0.04,"bidSize":75000,"shortable":3,"etf":0,"ttmEps":-0.007681,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770786000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.041,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AT1.AU\",,,,,undefined,":{"symbol":"AT1.AU","floatShares":423507786,"roa":"-35.32%","roe":"-58.27%","lyrEps":-0.007681,"shares":810175282,"dividePrice":0,"high":0.041,"amplitude":0,"preClose":0.041,"low":0.041,"week52Low":0.014,"pbRate":"4.76","psRate":"8.76","week52High":0.048,"institutionHeld":0,"latestPrice":0.041,"committee":-0.583333,"eps":-0.007681,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.007681,"open":0.041,"prevYearClose":0.036,"prevWeekClose":0.04,"prevMonthClose":0.038,"prevQuarterClose":0.036,"fiveDayClose":0.042,"twentyDayClose":0.036,"sixtyDayClose":0.027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AT1.AU\",params:#limit:5,,,undefined,":[{"date":"2026-01-27","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769468400000,"name":null,"time":"","dateTimestamp":1769432400000,"actualEps":null},{"date":"2025-10-28","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761606000000,"name":null,"time":"","dateTimestamp":1761570000000,"actualEps":null},{"date":"2025-08-29","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-07-29","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753747200000,"name":null,"time":"","dateTimestamp":1753711200000,"actualEps":null},{"date":"2025-04-24","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745452800000,"name":null,"time":"","dateTimestamp":1745416800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AT1.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AT1.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604302152","title":"BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal","url":"https://stock-news.laohu8.com/highlight/detail?id=2604302152","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604302152?lang=en_us&edition=fundamental","pubTime":"2026-01-20 09:15","pubTimestamp":1768871707,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On PascalJan 20  - Atomo Diagnostics Ltd AT1.AX:EXCLUSIVE LICENCE FOR A NOVEL LIVER FUNCTION TEST ON PASCALAGREEMENT WITH BURNET DIAGNOSTICS INITIATIVEFurther company coverage: AT1.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AT1.AU","BK7007","BK7501"],"gpt_icon":0},{"id":"2604154385","title":"BUZZ-Australia's Atomo Diagnostics jumps on new liver test license","url":"https://stock-news.laohu8.com/highlight/detail?id=2604154385","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604154385?lang=en_us&edition=fundamental","pubTime":"2026-01-20 08:40","pubTimestamp":1768869631,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Atomo Diagnostics jumps on new liver test license** Atomo Diagnostics AT1.AX jumps 11.4% to A$0.039; set for strongest trading session since December 9, 2025** Medical devices co signs exclusive global licensing agreement with Burnet Diagnostics Initiative for novel liver function test** Says license for Burnet's liver function test supports commercialisation of rapid test for immediate detection of liver injury** Test can be administered via co's self-testing device Pascal cassette** YTD, AT1 up 5.6%; had risen 89.5% in 2025  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL6N3YL01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2604568961","title":"Atomo Diagnostics - Agreement With Burnet Diagnostics Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2604568961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604568961?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:31","pubTimestamp":1768861901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2604156893","title":"Atomo Diagnostics - Exclusive Licence for a Novel Liver Function Test on Pascal","url":"https://stock-news.laohu8.com/highlight/detail?id=2604156893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604156893?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:31","pubTimestamp":1768861901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","AT1.AU","BK7007"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AT1.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":-0.082319}]}}